UNICA IRIS Institutional Research Information System

LA NASA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 288.420
NA - Nord America 24.395
AS - Asia 11.788
SA - Sud America 1.898
AF - Africa 333
OC - Oceania 108
Continente sconosciuto - Info sul continente non disponibili 8
Totale 326.950
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 277.799
US - Stati Uniti d'America 23.943
SG - Singapore 4.393
CN - Cina 3.894
NL - Olanda 3.329
UA - Ucraina 1.851
SE - Svezia 1.514
BR - Brasile 1.456
VN - Vietnam 1.043
FI - Finlandia 912
DE - Germania 869
GB - Regno Unito 742
FR - Francia 651
HK - Hong Kong 474
IN - India 399
KR - Corea 320
CA - Canada 265
BD - Bangladesh 173
JP - Giappone 163
AR - Argentina 156
IQ - Iraq 142
MX - Messico 112
TR - Turchia 111
PL - Polonia 106
RU - Federazione Russa 102
ZA - Sudafrica 99
IE - Irlanda 97
AU - Australia 94
PK - Pakistan 89
AT - Austria 87
ES - Italia 72
ID - Indonesia 69
IR - Iran 69
EC - Ecuador 68
SA - Arabia Saudita 61
CO - Colombia 55
MY - Malesia 52
MA - Marocco 50
EG - Egitto 48
VE - Venezuela 46
UZ - Uzbekistan 44
PH - Filippine 43
BE - Belgio 38
CL - Cile 34
CZ - Repubblica Ceca 33
CH - Svizzera 30
LT - Lituania 28
IL - Israele 27
JO - Giordania 25
RO - Romania 25
PY - Paraguay 24
AE - Emirati Arabi Uniti 23
ET - Etiopia 23
DK - Danimarca 22
TH - Thailandia 22
JM - Giamaica 21
KE - Kenya 20
KZ - Kazakistan 20
PE - Perù 20
NP - Nepal 17
TN - Tunisia 17
TW - Taiwan 17
UY - Uruguay 17
AZ - Azerbaigian 15
OM - Oman 14
PT - Portogallo 14
DZ - Algeria 13
HU - Ungheria 13
MU - Mauritius 13
NZ - Nuova Zelanda 12
BO - Bolivia 11
PS - Palestinian Territory 11
DO - Repubblica Dominicana 10
IS - Islanda 10
LB - Libano 10
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
EU - Europa 8
GE - Georgia 8
SD - Sudan 8
AL - Albania 7
BG - Bulgaria 7
BY - Bielorussia 7
GR - Grecia 7
NO - Norvegia 7
PA - Panama 7
TZ - Tanzania 7
CR - Costa Rica 6
GY - Guiana 6
HN - Honduras 6
JE - Jersey 6
NG - Nigeria 6
PR - Porto Rico 6
RS - Serbia 6
SN - Senegal 6
AO - Angola 5
CY - Cipro 5
QA - Qatar 5
AM - Armenia 4
HR - Croazia 4
Totale 326.873
Salva come PNG Salva come JPEG
Città #
Cagliari 267.793
Uta 7.753
Amsterdam 3.198
Singapore 2.118
Ashburn 2.112
Fairfield 1.950
Woodbridge 1.624
Chandler 1.472
San Jose 1.455
Boardman 1.267
Dallas 1.156
Houston 1.070
Ann Arbor 1.016
Jacksonville 952
Wilmington 856
Nyköping 847
Seattle 762
Beijing 710
Cambridge 668
Helsinki 591
New York 524
Los Angeles 517
Hefei 406
Hong Kong 401
Council Bluffs 374
Lauterbourg 328
Nanjing 316
Boston 305
Ho Chi Minh City 303
Santa Clara 265
The Dalles 263
Seoul 246
Milan 215
Dearborn 211
Hanoi 204
Munich 198
Shanghai 185
Buffalo 182
Rome 157
Dong Ket 150
San Diego 143
São Paulo 135
Orem 107
Shenyang 103
Guangzhou 101
Toronto 91
Hebei 90
Changsha 89
Tokyo 88
Nanchang 83
Tianjin 82
Redondo Beach 81
Frankfurt am Main 80
Verona 80
Atlanta 78
London 77
Chicago 73
Redwood City 73
Warsaw 70
Nuremberg 69
Rio de Janeiro 69
Jiaxing 65
Washington 65
Orange 61
Dublin 60
Baghdad 59
Menlo Park 59
Brooklyn 58
Pune 56
Montreal 55
Denver 52
Mountain View 51
Phoenix 51
Vienna 51
Norwalk 50
Sassari 49
Chennai 48
Da Nang 45
Stockholm 40
Tashkent 40
Jinan 38
Johannesburg 37
Sydney 37
Incheon 36
Mumbai 36
Brussels 35
Haiphong 34
Manchester 34
San Francisco 34
Ningbo 32
Wuhan 32
Ankara 28
Auburn Hills 28
Columbus 28
New Delhi 28
Turku 28
Brasília 27
Istanbul 27
Redmond 27
Zhengzhou 27
Totale 308.630
Salva come PNG Salva come JPEG
Nome #
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis 4.572
HLA-G expression and role in advanced-stage classical Hodgkin lymphoma 3.585
The impact of NOD2/CARD15 SNPs on the severe gastrointestinal GVHD following allogeneic Stem Cell Transplantation in Sardinia population 3.449
Comparison Between an Artificial Neural Network and Logistic Regression in Predicting Long Term Kidney Transplantation Outcome 3.434
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.405
Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma 3.368
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients 3.349
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.320
What unrelated hematopoietic stem cell transplantation in thalassemia taught us about transplant immunogenetics 3.318
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients 3.314
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia 3.237
Reassessing the approach to informed consent: The case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 3.053
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.915
Kir haplotype aa is a possible predictive marker of complete molecular response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia 2.828
Ruolo del trapianto allogenico nelle talassemie 2.786
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma 2.748
Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib 2.720
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 2.610
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients 2.604
In vitro ovine articular chondrocyte proliferation: experiments and modelling 2.551
A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromes 2.525
Experimental analysis and modelling of in vitro proliferation of mesenchymal stem cells 2.257
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia 2.255
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.250
Health related quality of life in patients with onco-hematological diseases 2.237
Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib 2.195
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.168
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 2.126
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 2.118
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 2.114
Homozygosity for Killer Immunoglobin-like Receptor (KIR) Haplotype a Is Associated to Negative Interim Positron Emission Tomography (PET) and a Favourable Outcome in Hodgkin Lymphoma 2.058
Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 1.993
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.969
Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study 1.967
Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia 1.961
Ruxolitinib therapy and telomere length in myelofibrosis 1.959
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life 1.939
Experimental analysis and modeling of in vitro mesenchymal stem cells proliferation 1.920
Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature 1.901
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice 1.878
Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis 1.839
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors 1.839
THE HLA-G 14-BP POLYMORPHISM IS AN INDEPENDENT GENETIC RISK MARKER OF LONG-TERM KIDNEY TRANSPLANTATION OUTCOME 1.814
The human leukocyte antigen-g 14-bp polymorphism is an independent genetic risk marker of long-term kidney transplantation outcome 1.760
null 1.759
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review 1.752
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting 1.681
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 1.618
Acute basophilic leukemia with U2AF1 mutation 1.595
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.585
Systemic Mastocytosis with Associated Primary Myelofibrosis 1.577
Unrelated bone marrow transplantation in Thalassemia. The experience of the Italian Bone Marrow transplant Group (GITMO) 1.555
T cell tyrosine phosphorylation response to transient redox stress 1.553
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib 1.536
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes 1.535
Erythroblast morphology in refractory anemia with ring sideroblasts and thrombocytosis 1.533
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 1.506
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.486
Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report 1.470
Successful and safe stem cell mobilization using plerixafor in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia 1.467
Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party 1.461
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 1.460
Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation 1.451
Perls stain grade in bone marrow aspirate correlates with overall survival in low-risk myelodysplastic patients 1.449
Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors 1.443
null 1.419
Resolution of capillary leak syndrome by extracorporeal membrane oxygenation 1.411
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients 1.400
Improved outcomes With retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial 1.370
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation 1.368
The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study 1.364
Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia 1.343
Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm 1.338
Immunological deregulation in classic hodgkin lymphoma 1.324
A simulated case of chronic myeloid leukemia: the growing risk of Munchausen’s Syndrome by internet 1.322
Rectal involvement in pre-early T acute lymphoblastic leukemia 1.309
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated donor hematopoietic stem cell transplantation in thalassemia patients 1.303
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 1.296
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 1.279
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.236
The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression? 1.233
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia 1.231
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.226
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 1.225
Could there be Haemodynamic Stress Effects on Pro-Inflammatory CD14+CD16+ Monocytes during Convective-Diffusive Treatments? A Prospective Randomized Controlled Trial 1.219
The role of inhibitory KIR 2DL5 in the outcome of autologous hematopoietic stem cell transplantation for multiple myeloma 1.217
Multiple myeloma treatment in real-world clinical practice: Results of a prospective, multinational, noninterventional study 1.206
Immunohistochemical findings in the lungs of COVID-19 subjects: Evidence of surfactant dysregulation 1.206
White Blood Cell Count Nadir and Duration of Aplasia Do Not Associate with Treatment Outcome in Adult Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy 1.202
Expression of l1 cell adhesion molecule (l1cam) in extracellular vesicles in the human spinal cord during development 1.199
Stem cell transplantation for congenital dyserythropoietic anemia. An analysis from the European society for blood and marrow transplantation 1.196
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation: a crystal ball to foresee the future? 1.172
Dasatinib first-line: multicentric Italian experience outside clinical trials 1.165
Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two ABVD cycles: Long-term results of the GITIL/FIL HD 0607 trial 1.165
null 1.138
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated haematopoietic stem cell transplantation 1.131
null 1.128
null 1.110
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity 1.107
Fetal programming of atherosclerosis: may the barker hypothesis explain the susceptibility of a subset of patients to develop stroke or cardiac infarct? 1.090
Totale 188.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 471.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 471.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.257 0 0 0 0 0 0 0 0 0 0 0 2.257
2021/202217.937 1.650 1.598 760 1.108 1.369 1.078 857 1.108 1.518 2.163 2.377 2.351
2022/202325.815 2.001 2.970 2.705 1.991 2.030 2.703 1.279 3.292 1.629 1.580 2.425 1.210
2023/202429.541 1.598 1.200 1.519 2.189 2.610 4.937 3.738 2.052 1.522 2.385 2.983 2.808
2024/202558.229 9.818 10.782 9.877 6.931 3.620 6.636 3.175 487 1.063 3.964 829 1.047
2025/202622.196 1.362 955 2.691 1.967 1.543 1.418 5.298 891 1.644 2.157 1.231 1.039
Totale 328.035